Collectively, these two studies provide clues regarding possible therapeutic targets for treatment of obesity and insulin resistance, implicating exercise-induced IL-6 may be required to achieve weight loss and improve glucose homeostasis. Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.